Reliable extraction of trial characteristics and outcomes is essential for systematic reviews, yet incorrect values can alter evidence synthesis and are difficult to detect without clear source evidence. We evaluate EviSearch, a clinical evidence-curation system that links extracted values to source passages, independe...
Gaurav Najpande, P. Titiya, Muhammad Ali Khan et al.· bioRxiv· 0 citations
Futibatinib plus pembrolizumab demonstrated an acceptable safety profile but did not meet efficacy thresholds supporting further study in FGF19-expressing HCC, an unmet need after first-line immunotherapy.
Nguyen H. Tran, M. Palmer, Angela Ulrich et al.· The Oncologist· 0 citations
The current evidence supporting biomarker-driven treatment strategies in advanced GEA is summarized, practical biomarker testing considerations are highlighted, and ongoing challenges and future directions in precision oncology are discussed.
Fares Jamal, Abdullah Alsulaiman, Oudai Sahwan et al.· Oncology Research· 0 citations
This case highlights the co-occurrence of an NF1 variant and dMMR colorectal cancer and underscores the need for further studies to determine whether this represents a coincidental finding or a biologically meaningful association.
Feras Alsabagh, Karam M. Chaaban, M. Girardo et al.· Exploration of neuroscience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
